Skip to main content
Fig. 2 | BMC Psychiatry

Fig. 2

From: The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial

Fig. 2

Measurements and time points. Abbreviations: SCID-5: Structured Clinical Interview for DSM-V; C-SSRS: Columbia suicide severity rating scale; MADRS: Montgomery–Asberg Depression Rating Scale; HAMD-17: 17-item Hamilton Rating Scale for Depression: SSI-5: The first five items of Baker Suicide Scale: HAMA: Hamilton Anxiety Scale [34]; CADSS: Clinician Administered Dissociative Symptoms Scale; YMRS: Young Mania Rating Scale; BPRS: Brief Psychiatric Rating Scale positive symptoms [35]; SDS: Severity Dependence Scale; VAS: Visual Analog Scale; MCCB: Measurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Battery; GAF: Global Assessment Function [36]; PHQ-9: Patien Health Questionnare-9 [37]; BPIC-SS: Bladder Pain/Interstitial Cystitis- Symptom Score [38]; SATEE: Systematic Assessment for Treatment Emergent Events; NSSI: Non-suicide Self-inflicted Injury

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us